Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Hackeng

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
Bone and Mineral|July 1, 1988
Abnormal responsiveness of nephrogenous cyclic AMP excretion following intravenously administered calcium in normocalcaemic squamous cell cancer patientsM A Naafs, W H Hackeng, G Koorevaar, et al.
Clinical Endocrinology|June 1, 1982
Analysis of factors in hyperthyroidism, which determine the duration of suppressive treatment before recovery of thyroid stimulating hormone secretionH R Fischer, W H Hackeng, W Schopman, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1993
Normocalcaemic hyperparathyroidism after parathyroidectomy: a retrospective studyH Mulder, J Koster, W H Hackeng, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1986
Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patientsW H Hackeng, P Lips, J C Netelenbos, et al.
Calcified Tissue International|July 1, 1992
Normocalcemia with persistent increase of parathyroid hormone: a prospective studyH Mulder, W H Hackeng, J Koster, et al.
Bone and Mineral|December 1, 1993
Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1-84)) in patients with primary hyperparathyroidismL van Doorn, P Lips, J C Netelenbos, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1986
Intact parathyroid hormone (1-84) in primary hypertensionD E Grobbee, W H Hackeng, J C Birkenhager, et al.
British Medical Journal (Clinical Research Ed.)|March 19, 1988
Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressureD E Grobbee, W H Hackeng, J C Birkenhäger, et al.
The Journal of Endocrinology|March 1, 1983
Cyproheptadine and desmethylcyproheptadine directly inhibit the release of adrenocorticotrophin and beta-lipotrophin/beta-endorphin activity from the neurointermediate lobe of the rat pituitary glandS W Lamberts, E G Bons, P Uitterlinden, et al.
Calcified Tissue Research|May 1, 1977
Clinical use of a parathyroid hormone determinationS A Duursma, G A Indermaur, J A Raymakers, et al.
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Bone and Mineral|July 1, 1988
Abnormal responsiveness of nephrogenous cyclic AMP excretion following intravenously administered calcium in normocalcaemic squamous cell cancer patientsM A Naafs, W H Hackeng, G Koorevaar, et al.
Clinical Endocrinology|June 1, 1982
Analysis of factors in hyperthyroidism, which determine the duration of suppressive treatment before recovery of thyroid stimulating hormone secretionH R Fischer, W H Hackeng, W Schopman, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1993
Normocalcaemic hyperparathyroidism after parathyroidectomy: a retrospective studyH Mulder, J Koster, W H Hackeng, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1986
Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patientsW H Hackeng, P Lips, J C Netelenbos, et al.
Calcified Tissue International|July 1, 1992
Normocalcemia with persistent increase of parathyroid hormone: a prospective studyH Mulder, W H Hackeng, J Koster, et al.
Bone and Mineral|December 1, 1993
Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1-84)) in patients with primary hyperparathyroidismL van Doorn, P Lips, J C Netelenbos, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1986
Intact parathyroid hormone (1-84) in primary hypertensionD E Grobbee, W H Hackeng, J C Birkenhager, et al.
British Medical Journal (Clinical Research Ed.)|March 19, 1988
Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressureD E Grobbee, W H Hackeng, J C Birkenhäger, et al.
The Journal of Endocrinology|March 1, 1983
Cyproheptadine and desmethylcyproheptadine directly inhibit the release of adrenocorticotrophin and beta-lipotrophin/beta-endorphin activity from the neurointermediate lobe of the rat pituitary glandS W Lamberts, E G Bons, P Uitterlinden, et al.
Calcified Tissue Research|May 1, 1977
Clinical use of a parathyroid hormone determinationS A Duursma, G A Indermaur, J A Raymakers, et al.
Pageof 11